Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Comment on: The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers-Danlos syndrome in children: reply.

Grahame R.

Rheumatology (Oxford). 2018 Dec 1;57(12):2250-2251. doi: 10.1093/rheumatology/key252. No abstract available.

PMID:
30239979
2.

The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers-Danlos syndrome in children: New research data conflict with widely held views.

Grahame R.

Rheumatology (Oxford). 2017 Dec 1;56(12):2048-2049. doi: 10.1093/rheumatology/kex241. No abstract available.

PMID:
29106635
3.

The 2017 international classification of the Ehlers-Danlos syndromes.

Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B.

Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26. doi: 10.1002/ajmg.c.31552.

PMID:
28306229
4.

Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.

Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H.

Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):48-69. doi: 10.1002/ajmg.c.31538. Epub 2017 Feb 1. Review.

PMID:
28145611
5.

A framework for the classification of joint hypermobility and related conditions.

Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A.

Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):148-157. doi: 10.1002/ajmg.c.31539. Epub 2017 Feb 1.

PMID:
28145606
6.

Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.

Gazit Y, Jacob G, Grahame R.

Rambam Maimonides Med J. 2016 Oct 31;7(4). doi: 10.5041/RMMJ.10261. Review.

7.

A connective tissue disorder may underlie ESSENCE problems in childhood.

Baeza-Velasco C, Grahame R, Bravo JF.

Res Dev Disabil. 2017 Jan;60:232-242. doi: 10.1016/j.ridd.2016.10.011. Epub 2016 Oct 29. Review.

PMID:
27802895
8.

Targeted next-generation sequencing makes new molecular diagnoses and expands genotype-phenotype relationship in Ehlers-Danlos syndrome.

Weerakkody RA, Vandrovcova J, Kanonidou C, Mueller M, Gampawar P, Ibrahim Y, Norsworthy P, Biggs J, Abdullah A, Ross D, Black HA, Ferguson D, Cheshire NJ, Kazkaz H, Grahame R, Ghali N, Vandersteen A, Pope FM, Aitman TJ.

Genet Med. 2016 Nov;18(11):1119-1127. doi: 10.1038/gim.2016.14. Epub 2016 Mar 24.

PMID:
27011056
9.

The association between Ehlers-Danlos syndrome-hypermobility type and gastrointestinal symptoms in university students: a cross-sectional study.

Fikree A, Aktar R, Morris JK, Grahame R, Knowles CH, Aziz Q.

Neurogastroenterol Motil. 2017 Mar;29(3). doi: 10.1111/nmo.12942. Epub 2016 Sep 28.

PMID:
27683076
10.

Ehlers-Danlos syndrome.

Grahame R.

S Afr Med J. 2016 May 25;106(6 Suppl 1):S45-6. doi: 10.7196/SAMJ.2016.v106i6.10991.

PMID:
27245524
11.

How do people with chronically painful joint hypermobility syndrome make decisions about activity?

Schmidt A, Corcoran K, Grahame R, de C Williams AC.

Br J Pain. 2015 Aug;9(3):157-66. doi: 10.1177/2049463714554112.

12.

Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: a case-control study.

Fikree A, Aktar R, Grahame R, Hakim AJ, Morris JK, Knowles CH, Aziz Q.

Neurogastroenterol Motil. 2015 Apr;27(4):569-79. doi: 10.1111/nmo.12535.

PMID:
25817057
13.

Recognizing the scale of joint hypermobility burden: comment on the article by Mulvey et al.

Hakim AJ, Grahame R.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):496. doi: 10.1002/acr.22221. No abstract available.

14.

Efficacy of an out-patient pain management programme for people with joint hypermobility syndrome.

Rahman A, Daniel C, Grahame R.

Clin Rheumatol. 2014 Nov;33(11):1665-9. doi: 10.1007/s10067-014-2539-9. Epub 2014 Feb 21.

PMID:
24557080
15.

A prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms.

Fikree A, Grahame R, Aktar R, Farmer AD, Hakim AJ, Morris JK, Knowles CH, Aziz Q.

Clin Gastroenterol Hepatol. 2014 Oct;12(10):1680-87.e2. doi: 10.1016/j.cgh.2014.01.014. Epub 2014 Jan 16.

PMID:
24440216
16.

Joint hypermobility: emerging disease or illness behaviour?

Grahame R.

Clin Med (Lond). 2013 Dec;13 Suppl 6:s50-2. doi: 10.7861/clinmedicine.13-6-s50.

PMID:
24298184
17.

Joint hypermobility syndrome.

Fikree A, Aziz Q, Grahame R.

Rheum Dis Clin North Am. 2013 May;39(2):419-30. doi: 10.1016/j.rdc.2013.03.003. Review.

PMID:
23597972
18.

Arachnodactyly--a key to diagnosing heritable disorders of connective tissue.

Grahame R, Hakim AJ.

Nat Rev Rheumatol. 2013 Jun;9(6):358-64. doi: 10.1038/nrrheum.2013.24. Epub 2013 Mar 12. Review.

PMID:
23478494
19.

Lower urinary tract symptoms in women with benign joint hypermobility syndrome: a case-control study.

Mastoroudes H, Giarenis I, Cardozo L, Srikrishna S, Vella M, Robinson D, Kazkaz H, Grahame R.

Int Urogynecol J. 2013 Sep;24(9):1553-8. doi: 10.1007/s00192-013-2065-3. Epub 2013 Feb 23.

PMID:
23436036
20.

Prolapse and sexual function in women with benign joint hypermobility syndrome.

Mastoroudes H, Giarenis I, Cardozo L, Srikrishna S, Vella M, Robinson D, Kazkaz H, Grahame R.

BJOG. 2013 Jan;120(2):187-192. doi: 10.1111/1471-0528.12082.

21.

Letter to editor.

Grahame R, Keer R, Simmonds J.

Man Ther. 2013 Apr;18(2):e9. doi: 10.1016/j.math.2012.05.015. Epub 2012 Jun 28. No abstract available.

PMID:
22749106
22.

Postural tachycardia syndrome--current experience and concepts.

Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R.

Nat Rev Neurol. 2011 Dec 6;8(1):22-34. doi: 10.1038/nrneurol.2011.187. Review.

PMID:
22143364
23.

Need for a consensus on the methods by which to measure joint mobility and the definition of norms for hypermobility that reflect age, gender and ethnic-dependent variation: is revision of criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type indicated?

Remvig L, Engelbert RH, Berglund B, Bulbena A, Byers PH, Grahame R, Juul-Kristensen B, Lindgren KA, Uitto J, Wekre LL.

Rheumatology (Oxford). 2011 Jun;50(6):1169-71. doi: 10.1093/rheumatology/ker140. Epub 2011 Apr 10. No abstract available.

PMID:
21482540
24.

Joint hypermobility syndrome.

Ross J, Grahame R.

BMJ. 2011 Jan 20;342:c7167. doi: 10.1136/bmj.c7167. No abstract available.

PMID:
21252103
25.

Joint hypermobility and rectal evacuatory dysfunction: an etiological link in abnormal connective tissue?

Mohammed SD, Lunniss PJ, Zarate N, Farmer AD, Grahame R, Aziz Q, Scott SM.

Neurogastroenterol Motil. 2010 Oct;22(10):1085-e283. doi: 10.1111/j.1365-2982.2010.01562.x. Epub 2010 Jul 5.

PMID:
20618831
26.

A novel in vivo skin extensibility test for joint hypermobility.

Farmer AD, Douthwaite H, Gardiner S, Aziz Q, Grahame R.

J Rheumatol. 2010 Jul;37(7):1513-8. doi: 10.3899/jrheum.091192. Epub 2010 Jun 15.

PMID:
20551108
27.

Joint hypermobility syndrome pain.

Grahame R.

Curr Pain Headache Rep. 2009 Dec;13(6):427-33. Review.

PMID:
19889283
28.

The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome).

Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D.

Am J Med Genet A. 2009 Nov;149A(11):2368-70. doi: 10.1002/ajmg.a.33070. No abstract available.

PMID:
19842204
29.

Unexplained gastrointestinal symptoms and joint hypermobility: is connective tissue the missing link?

Zarate N, Farmer AD, Grahame R, Mohammed SD, Knowles CH, Scott SM, Aziz Q.

Neurogastroenterol Motil. 2010 Mar;22(3):252-e78. doi: 10.1111/j.1365-2982.2009.01421.x. Epub 2009 Oct 15.

PMID:
19840271
30.

Injury and joint hypermobility syndrome in ballet dancers--a 5-year follow-up.

Briggs J, McCormack M, Hakim AJ, Grahame R.

Rheumatology (Oxford). 2009 Dec;48(12):1613-4. doi: 10.1093/rheumatology/kep175. Epub 2009 Jul 9. No abstract available.

PMID:
19589896
31.

Hypermobility: an important but often neglected area within rheumatology.

Grahame R.

Nat Clin Pract Rheumatol. 2008 Oct;4(10):522-4. doi: 10.1038/ncprheum0907. Epub 2008 Sep 2. No abstract available.

PMID:
18762785
32.

Hypermobility.

Grahame R, Hakim AJ.

Curr Opin Rheumatol. 2008 Jan;20(1):106-10. doi: 10.1097/BOR.0b013e3282f31790. Review.

PMID:
18281866
33.

Is there still a place for colchicine in the treatment of acute gout?

Grahame R.

Int J Clin Pract. 2007 Dec;61(12):1966-7. No abstract available.

PMID:
17997801
34.

The need to take a fresh look at criteria for hypermobility.

Grahame R.

J Rheumatol. 2007 Apr;34(4):664-5. No abstract available.

PMID:
17407226
35.

The genetic basis of the joint hypermobility syndromes.

Malfait F, Hakim AJ, De Paepe A, Grahame R.

Rheumatology (Oxford). 2006 May;45(5):502-7. Epub 2006 Jan 17. Review. No abstract available.

PMID:
16418200
36.

Joint hypermobility syndrome in childhood. A not so benign multisystem disorder?

Adib N, Davies K, Grahame R, Woo P, Murray KJ.

Rheumatology (Oxford). 2005 Jun;44(6):744-50. Epub 2005 Feb 22.

PMID:
15728418
37.

Local anaesthetic failure in joint hypermobility syndrome.

Hakim AJ, Grahame R, Norris P, Hopper C.

J R Soc Med. 2005 Feb;98(2):84-5. No abstract available.

38.

Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects.

Zweers MC, Hakim AJ, Grahame R, Schalkwijk J.

Arthritis Rheum. 2004 Sep;50(9):2742-9. Review. No abstract available.

39.

The genetic epidemiology of joint hypermobility: a population study of female twins.

Hakim AJ, Cherkas LF, Grahame R, Spector TD, MacGregor AJ.

Arthritis Rheum. 2004 Aug;50(8):2640-4.

40.

Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction?

Hakim AJ, Grahame R.

Rheumatology (Oxford). 2004 Sep;43(9):1194-5. No abstract available.

PMID:
15317957
41.

Joint hypermobility.

Hakim A, Grahame R.

Best Pract Res Clin Rheumatol. 2003 Dec;17(6):989-1004. Review.

PMID:
15123047
42.

Joint laxity and the benign joint hypermobility syndrome in student and professional ballet dancers.

McCormack M, Briggs J, Hakim A, Grahame R.

J Rheumatol. 2004 Jan;31(1):173-8.

PMID:
14705238
43.

Dysautonomia in the joint hypermobility syndrome.

Gazit Y, Nahir AM, Grahame R, Jacob G.

Am J Med. 2003 Jul;115(1):33-40.

PMID:
12867232
44.

Connective tissue naevus (collagenoma) in a patient with benign joint hypermobility syndrome (Ehlers-Danlos syndrome type III).

Sidwell RU, Francis N, Grahame R, Pope FM, Bunker CB.

Clin Exp Dermatol. 2003 May;28(3):323-5. No abstract available.

PMID:
12780726
45.
46.

The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford Study.

Dolan AL, Hart DJ, Doyle DV, Grahame R, Spector TD.

J Rheumatol. 2003 Apr;30(4):799-803.

PMID:
12672202
47.

Hypermobility in New Zealand.

Grahame R, Bird H.

Rheumatology (Oxford). 2003 Mar;42(3):491; author reply 491-2. No abstract available.

PMID:
12626808
48.

Severe periodontitis in Marfan's syndrome: a case report.

Straub AM, Grahame R, Scully C, Tonetti MS.

J Periodontol. 2002 Jul;73(7):823-6.

PMID:
12146542
49.

The decline of rehabilitation services and its impact on disability benefits.

Grahame R.

J R Soc Med. 2002 Mar;95(3):114-7. No abstract available.

50.

British consultant rheumatologists' perceptions about the hypermobility syndrome: a national survey.

Grahame R, Bird H.

Rheumatology (Oxford). 2001 May;40(5):559-62.

PMID:
11371666

Supplemental Content

Loading ...
Support Center